N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.59p
   
  • Change Today:
    -0.057p
  • 52 Week High: 0.62
  • 52 Week Low: 0.59
  • Currency: UK Pounds
  • Shares Issued: 832.28m
  • Volume: 500,000
  • Market Cap: £4.93m

N4 Pharma Overview

We’re N4 Pharma, a specialist pharmaceutical company developing a novel silica nanoparticle delivery system for vaccines and therapeutics for licensing to pharmaceutical and biotech partners. This nanoparticle has the potential to help commercialise cancer immunotherapy drugs and improve the effectiveness of viral vaccines.
Registrars: Capita Registrars

Key Personnel

CEO: Nigel Theobald
Executive Director: Luke Cairns
Independent Non-Executive Director: Alastair Smith
Non-Executive Chairman: Chris Britten
Non-Executive Dir: Edward Wardle , Michael Palfreyman

Contact Details

Address: C/O Arch Law Huckletree Bishopsgate, 8 Bishopsgate, London, United Kingdom, EC2N 4BQ
Website: http://www.n4pharma.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BYW8QM32

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

N4 Pharma Market Data

Currency UK Pounds
Share Price 0.59p
Change Today -0.057p
% Change -8.79 %
52 Week High 0.62
52 Week Low 0.59
Volume 500,000
Shares Issued 832.28m
Market Cap £4.93m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average
70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average
Value
55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average
70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average
Income Not Available
Growth
25.67% above the market average25.67% above the market average25.67% above the market average25.67% above the market average25.67% above the market average
17.24% above the sector average17.24% above the sector average17.24% above the sector average17.24% above the sector average17.24% above the sector average

N4 Pharma Dividends

No dividends found

Trades for 28-Oct-2025

Time Volume / Share Price
08:59 500,000 @ 0.62p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page